600+ sources. One page. See who else covered it.
☢️ Curium spends $8B for Lantheus: Curium is buying fellow radiopharma company Lantheus for $102.5 per share. Lantheus shareholders may receive $12 more per share if certain targets are achieved ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
While Black and Hispanic families are enthusiastic about research participation, other provider- and system-focused factors may influence their involvement in pediatric oncology clinical trials, a UT…
In a clinical trial of adults with HIV-related cryptococcal disease, those treated with a two-drug combination had a 21% lower risk of dying than those treated with just one drug.
The transaction combines two companies marketing nearly a dozen neurological drugs that bring in steady, but not blockbuster sales for conditions such as opioid use disorder and Parkinson's.
Health Secretary Robert F. Kennedy Jr. on Sunday endorsed the measles vaccine while also pushing a string of false and debunked assertions about other vaccines, RSV and the ongoing measles outbreaks.
(MedPage Today) -- In "Beyond Diagnosis: Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell conclude their discussions on communicating…
"What are you really expecting them to say?" the HBO host asks The post John Oliver Scoffs at CDC’s Advice to ‘Play Lettuce Detective’ to Avoid Cyclospora appeared first on TheWrap .